Dashboard
Manage Tickers

BMY


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bernie-sanders-says-if-youre-poor-in-america-youll-live-10-15-years-less-anybody-else-see-a-problem-with-that
Bernie Sanders Says If You're Poor In Amer...
09/10/2024 02:12:36

enliven-therapeutics-leukemia-candidate-could-challenge-pfizer-astrazeneca-in-broader-target-market-analyst
Enliven Therapeutics' Leukemia Candidate C...
09/09/2024 18:05:21

HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC Wainwr...

fda-battles-backlog-of-drug-factory-inspections-since-covid-19
FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs
Despite Medicare Negotiations, Americans M...
09/03/2024 19:12:09

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

reported-earlier-bristol-myers-squibb-presents-35-year-data-on-camzyos-at-esc-2024
Reported Earlier, Bristol Myers Squibb Pre...
09/03/2024 07:28:31

Bristol Myers Squibb (NYSE:BMY) today announced new long-term follow-up results from the EXPLORER-LTE cohort of the MAVA-Long-T...

jefferies-maintains-hold-on-bristol-myers-squibb-raises-price-target-to-51
Jefferies Maintains Hold on Bristol-Myers ...
08/28/2024 18:44:01

Jefferies analyst Akash Tewari maintains Bristol-Myers Squibb (NYSE:BMY) with a Hold and raises the price target from $49 to...

as-regulators-gear-up-to-decide-on-bristol-myers-schizophrenia-treatment-neurocrine-biosciences-data-disappoints-investors
As Regulators Gear Up To Decide On Bristol...
08/28/2024 15:16:26

Neurocrine Biosciences reports Phase 2 trial results for NBI-1117568 showing significant improvement in schizophrenia symptoms,...

kohls-posts-upbeat-q2-earnings-joins-box-waldencast-aerovironment-and-other-big-stocks-moving-higher-on-wednesday
Kohl's Posts Upbeat Q2 Earnings, Joins Box...
08/28/2024 14:17:42

regulators-expected-to-approve-innovative-schizophrenia-treatment-from-bristol-myers-karuna
Regulators Expected To Approve Innovative ...
08/27/2024 19:22:11

Drug companies are investing in schizophrenia treatments as patients are desperate for a drug that has few side effects, Bloomb...

market-whales-and-their-recent-bets-on-bmy-options
Market Whales and Their Recent Bets on BMY...
08/27/2024 18:30:48

bristol-myers-squibb-to-present-new-findings-on-camzyos-eliquis-and-milvexian-cardiovascular-treatments-at-esc-congress
Bristol Myers Squibb To Present New Findin...
08/26/2024 11:01:15

Bristol Myers Squibb (NYSE:BMY) today announced the presentation of research across its robust cardiovascular portfolio at the ...

cancer-medicines-from-merck-bristol-myers-and-beigene-in-question-as-fda-committee-to-discuss-limiting-pd-1-drugs-for-stomach-cancer
Cancer Medicines From Merck, Bristol Myers...
08/23/2024 18:10:48

The FDA's Oncologic Drugs Advisory Committee will meet on September 26 to reevaluate the approvals of checkpoint inhibitors...

bristol-myers-squibb-says-fda-schedules-oncologic-drugs-advisory-committee-meeting-for-september-26-to-discuss-pd-l1-expression-levels-in-gastric-and-esophageal-cancers
Bristol-Myers Squibb Says FDA Schedules On...
08/22/2024 19:08:36

- Reuters 

key-takeaways-from-bristol-myers-squibb-analyst-ratings
Key Takeaways From Bristol-Myers Squibb An...
08/22/2024 15:00:16

barclays-maintains-underweight-on-bristol-myers-squibb-raises-price-target-to-42
Barclays Maintains Underweight on Bristol-...
08/22/2024 14:15:41

Barclays analyst Carter Gould maintains Bristol-Myers Squibb (NYSE:BMY) with a Underweight and raises the price target from ...

bristol-myers-squibbs-options-frenzy-what-you-need-to-know
Bristol-Myers Squibb's Options Frenzy: Wha...
08/21/2024 19:46:02

the-fda-has-accepted-bristol-myers-squibbs-supplemental-biologics-license-application-for-opdivo-nivolumab-plus-yervoy-ipilimumab-as-potential-first-line-treatment-for-adult-patients-with-unresectable-hepatocellular-carcinoma-with-prescription-drug-user-fee-act-goal-date-of-april-21-2025
The FDA Has Accepted Bristol Myers Squibb'...
08/21/2024 11:04:30

ema-validates-bristol-myers-squibbs-application-for-breyanzi-in-treating-relapsed-follicular-lymphoma
EMA Validates Bristol Myers Squibb's Appli...
08/19/2024 11:01:52

Bristol Myers Squibb (NYSE:BMY) today announced that the European Medicines Agency (EMA) has validated its Type II variation ap...

check-out-what-whales-are-doing-with-bmy
Check Out What Whales Are Doing With BMY
08/16/2024 17:16:30

biden-administration-targets-6b-savings-through-medicare-drug-price-negotiations
Biden Administration Targets $6B Savings T...
08/15/2024 14:38:21

Medicare drug price negotiations, enabled by the Inflation Reduction Act, are set to save the U.S. government $6 billion.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION